a r&d company of therapeutics to extend the human healthspan
Industry Biotechnology
A.I.dvisor indicates that over the last year, UBX has been loosely correlated with CHRS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then CHRS could also see price increases.
Ticker / NAME | Correlation To UBX | 1D Price Change % | ||
---|---|---|---|---|
UBX | 100% | -4.91% | ||
CHRS - UBX | 36% Loosely correlated | -2.16% | ||
KOD - UBX | 35% Loosely correlated | -3.59% | ||
XFOR - UBX | 35% Loosely correlated | -5.80% | ||
ADPT - UBX | 35% Loosely correlated | -4.47% | ||
ACLX - UBX | 33% Poorly correlated | -3.81% | ||
More |
Ticker / NAME | Correlation To UBX | 1D Price Change % |
---|---|---|
UBX | 100% | -4.91% |
therapeutics theme (57 stocks) | 34% Loosely correlated | +20.54% |
drugs theme (265 stocks) | 33% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 30% Poorly correlated | +5.56% |
human theme (15 stocks) | 21% Poorly correlated | +1.59% |